Egrifta FDA Approved Drugs
EGRIFTA [Tesamorelin AcetateC221H366N72O67SC2H4O2]
RX
- eq 1mg base/vial (subcutaneous powder)
TheratechnologiesNov 10, 2010
- Reduction of excess abdominal fat in hiv-infected patients with lipodystrophy.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.